Endocrinology, Vol 122, 1034-1041, Copyright © 1988 by Endocrine Society

ARTICLES

Evidence for the involvement of endogenous opioids in the inhibition of luteinizing hormone by corticotropin-releasing factor

OF Almeida, KE Nikolarakis and A Herz
Department of Neuropharmacology, Max-Planck-Institut fur Psychiatrie, Planegg-Martinsried, Federal Republic of Germany.

Experiments were carried out in castrate adult male rats to further examine whether endogenous opioids are involved in CRF-induced suppression of LH secretion. Serum LH levels in rats castrated 5 days earlier were significantly reduced by intracerebroventricular administration of homologous (rat) CRF (0.02-2 nmol) within 30 min posttreatment; the effects of 0.02 nmol CRF lasted for at least 2 h, whereas those of 0.2 and 2 nmol CRF were evident for up to 6 h. Rats that received sc infusions of the opioid receptor antagonist naloxone (9.6 mg/kg.day) for 48 h before testing with 0.2 nmol CRF showed a significant reduction of the LH response to CRF. Rats that received two acute injections of naloxone (2 mg/kg, iv, 30 min apart) also showed an attenuated response to the LH-suppressive effects of CRF. In another experimental model where the opioidergic control of LH secretion is absent or masked, the long term castrate rat, there was also a marked attenuation of the LH-suppressing effects of CRF. Transient replacement of testosterone in long term castrates reinstated the inhibitory effects of CRF on LH secretion. A third experiment, in which short term castrates were pretreated with an opioid antibody and then with CRF, resulted in a significant reduction of the CRF-induced reduction of serum LH levels. These observations indicate that opioid receptor- mediated events play an important part in the actions of CRF on LH secretion. On the basis of our previous experiments in vitro, we propose that CRF stimulates the release of hypothalamic opioid peptides, which in turn inhibits the activity of LHRH neurons and, thus, LH secretion.

This article has been cited by other articles:

				N. J. Westphal and A. F. Seasholtz Gonadotropin-Releasing Hormone (GnRH) Positively Regulates Corticotropin-Releasing Hormone-Binding Protein Expression via Multiple Intracellular Signaling Pathways and a Multipartite GnRH Response Element in {alpha}T3-1 Cells Mol. Endocrinol., November 1, 2005; 19(11): 2780 - 2797. [Abstract] [Full Text] [PDF]

				J. E Bowe, X. F Li, J. S Kinsey-Jones, S Paterson, S. D Brain, S. L Lightman, and K. T O'Byrne Calcitonin gene-related peptide-induced suppression of luteinizing hormone pulses in the rat: the role of endogenous opioid peptides J. Physiol., August 1, 2005; 566(3): 921 - 928. [Abstract] [Full Text] [PDF]

				R. M. Sapolsky, L. M. Romero, and A. U. Munck How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions Endocr. Rev., February 1, 2000; 21(1): 55 - 89. [Abstract] [Full Text]

				K.-H. Jeong, L. Jacobson, E. P. Widmaier, and J. A. Majzoub Normal Suppression of the Reproductive Axis Following Stress in Corticotropin-Releasing Hormone-Deficient Mice Endocrinology, April 1, 1999; 140(4): 1702 - 1708. [Abstract] [Full Text]

				D. A. Van Vugt, J. Piercy, A. E. Farley, R. L. Reid, and S. Rivest Luteinizing Hormone Secretion and Corticotropin-Releasing Factor Gene Expression in the Paraventricular Nucleus of Rhesus Monkeys Following Cortisol Synthesis Inhibition Endocrinology, June 1, 1997; 138(6): 2249 - 2258. [Abstract] [Full Text] [PDF]